These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 34943602)

  • 1. The Summarized Assessment of Endothelin A Receptor Expression in Renal Transplant Compartments Associated with Antibody-Mediated Rejection.
    Banasik M; Kuriata-Kordek M; Donizy P; Nowańska K; Wiśnicki K; Letachowicz K; Zmonarski S; Kamińska D; Mazanowska O; Dawiskiba T; Janczak D; Hałoń A; Kepinska M; Uchmanowicz B; Zachciał J; Tukiendorf A; Krajewska M
    Diagnostics (Basel); 2021 Dec; 11(12):. PubMed ID: 34943602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelin A Receptors Expressed in Glomeruli of Renal Transplant Patients May Be Associated with Antibody-Mediated Rejection.
    Nowańska K; Banasik M; Donizy P; Kościelska-Kasprzak K; Zmonarski S; Letachowicz K; Kamińska D; Mazanowska O; Augustyniak-Bartosik H; Tukiendorf A; Chudiak A; Dawiskiba T; Hałoń A; Krajewska M
    J Clin Med; 2021 Jan; 10(3):. PubMed ID: 33499235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin A Receptors Expressed in Renal Blood Vessels of Renal Transplant Patients Are Connected With Acute Tubular Necrosis or Antibody-Mediated Rejection.
    Nowańska K; Donizy P; Kościelska-Kasprzak K; Kamińska D; Krajewska M; Mazanowska O; Madziarska K; Zmonarski S; Chudoba P; Małkiewicz B; Hałoń A; Klinger M; Banasik M
    Transplant Proc; 2018; 50(6):1760-1764. PubMed ID: 30056896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathological Relevance of Angiotensin II Type 1 Receptor in Renal Transplant Biopsy.
    Sas A; Donizy P; Kościelska-Kasprzak K; Kamińska D; Mazanowska O; Krajewska M; Chudoba P; Korta K; Hałoń A; Klinger M; Banasik M
    Transplant Proc; 2018; 50(6):1847-1849. PubMed ID: 30056913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of non-HLA antibodies directed against endothelin-1 type A receptors (ETAR) on early renal transplant outcomes.
    Banasik M; Boratyńska M; Kościelska-Kasprzak K; Krajewska M; Mazanowska O; Kamińska D; Bartoszek D; Zabińska M; Myszka M; Nowakowska B; Hałoń A; Dawiskiba T; Chudoba P; Klinger M
    Transpl Immunol; 2014 Jan; 30(1):24-9. PubMed ID: 24184747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of Total Lymphoid Irradiation, Low-Dose IVIG and ATG as Rescue Therapy for Highly Sensitized and Antibody-Mediated Rejection Renal Transplant Recipients.
    Zhu D; Qi G; Tang Q; Li L; Yang C; Lin M; Wu B; Xu M; Cai J; Zhu T; Rong R
    Clin Transpl; 2014; ():215-21. PubMed ID: 26281148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical study of endothelin-1 (ET-1) in human acute renal allograft rejection.
    Wagrowska-Danilewicz M; Danilewicz M
    Pol J Pathol; 2003; 54(2):95-100. PubMed ID: 14575417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
    Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J
    Clin Transpl; 2014; ():223-30. PubMed ID: 26281149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of Serum Angiotensin II Type 1 Receptor Antibodies at the Time of Renal Allograft Rejection.
    Lee H; Kim JI; Moon IS; Chung BH; Yang CW; Kim Y; Han K; Oh EJ
    Ann Lab Med; 2015 May; 35(3):314-20. PubMed ID: 25932439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular Matrix Injury of Kidney Allografts in Antibody-Mediated Rejection: A Proteomics Study.
    Clotet-Freixas S; McEvoy CM; Batruch I; Pastrello C; Kotlyar M; Van JAD; Arambewela M; Boshart A; Farkona S; Niu Y; Li Y; Famure O; Bozovic A; Kulasingam V; Chen P; Kim SJ; Chan E; Moshkelgosha S; Rahman SA; Das J; Martinu T; Juvet S; Jurisica I; Chruscinski A; John R; Konvalinka A
    J Am Soc Nephrol; 2020 Nov; 31(11):2705-2724. PubMed ID: 32900843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-HLA agonistic anti-angiotensin II type 1 receptor antibodies induce a distinctive phenotype of antibody-mediated rejection in kidney transplant recipients.
    Lefaucheur C; Viglietti D; Bouatou Y; Philippe A; Pievani D; Aubert O; Duong Van Huyen JP; Taupin JL; Glotz D; Legendre C; Loupy A; Halloran PF; Dragun D
    Kidney Int; 2019 Jul; 96(1):189-201. PubMed ID: 31005275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C1q Donor-Specific Antibody Associates with Post-transplant Biopsy Findings in Highly- Sensitized Kidney Transplant Recipients.
    Kuppachi S; Holanda D; Gallegos S; Field EH
    Clin Transpl; 2016; 32():127-134. PubMed ID: 28564530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of HLA-G transcripts in graft biopsy samples of renal transplant recipients.
    Žilinská Z; Bandžuchová H; Chrastina M; Trebatický B; Breza J; Handzušová M; Kuba D; Tirpáková J; Pavlechová M; Dedinská I; Rychlý B; Poláková K
    Transpl Immunol; 2015 Nov; 33(3):159-65. PubMed ID: 26455418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-glutathione S-transferase T1 antibody-mediated rejection in C4d-positive renal allograft recipients.
    Aguilera I; Alvarez-Marquez A; Gentil MA; Fernandez-Alonso J; Fijo J; Saez C; Wichmann I; Nuñez-Roldan A
    Nephrol Dial Transplant; 2008 Jul; 23(7):2393-8. PubMed ID: 18308775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute Antibody-Mediated Rejection in Kidney Transplant Based on the 2013 Banff Criteria: Single-Center Experience in Uruguay.
    Nin M; Coitiño R; Kurdian M; Orihuela L; Astesiano R; Garau M; López D; Rievas G; Rodriguez I; González-Martínez F; Noboa O
    Transplant Proc; 2016 Mar; 48(2):612-5. PubMed ID: 27110014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and pathological analyses of transplant glomerulopathy cases.
    Shimizu T; Ishida H; Toki D; Nozaki T; Omoto K; Tanabe K; Honda K; Koike J
    Nephrology (Carlton); 2014 Jun; 19 Suppl 3():21-6. PubMed ID: 24842817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of non-HLA antibodies directed against angiotensin II type 1 receptor (AT1R) on early renal transplant outcomes.
    Banasik M; Boratyńska M; Kościelska-Kasprzak K; Kamińska D; Bartoszek D; Zabińska M; Myszka M; Zmonarski S; Protasiewicz M; Nowakowska B; Hałoń A; Chudoba P; Klinger M
    Transpl Int; 2014 Oct; 27(10):1029-38. PubMed ID: 24909812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II Type 1 Receptor Expression in Renal Transplant Biopsies and Anti-AT1R Antibodies in Serum Indicates the Risk of Transplant Loss.
    Sas-Strózik A; Donizy P; Kościelska-Kasprzak K; Kamińska D; Gawlik K; Mazanowska O; Madziarska K; Hałoń A; Krajewska M; Banasik M
    Transplant Proc; 2020 Oct; 52(8):2299-2304. PubMed ID: 32448653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlations of lymphocyte subset infiltrates with donor-specific antibodies and acute antibody-mediated rejection in endomyocardial biopsies.
    Frank R; Dean SA; Molina MR; Kamoun M; Lal P
    Cardiovasc Pathol; 2015; 24(3):168-72. PubMed ID: 25440957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular assessment of antibody-mediated rejection in human pancreas allograft biopsies.
    Roufosse C; Drachenberg C; Renaudin K; Willicombe M; Toulza F; Dominy K; McLean A; Simmonds N; de Kort H; Cantarovitch D; Scalea J; Mengel M; Adam B
    Clin Transplant; 2020 Nov; 34(11):e14065. PubMed ID: 32805760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.